The company presented new data from its Alzheimer’s disease research efforts across its diagnostics and pharmaceutical ...

Portfolio Receipts was $727 million in the second quarter of 2025, an increase of 20% compared to $608 million in the second quarter of 2024, primarily driven by the same Royalty Receipts increases ...

See the latest Roche Holding AG ADR stock price (RHHBY:PINX), related news, valuation, dividends and more to help you make your investing decisions.

Roche’s move into digital pathology has been lifted by FDA approval of its digital pathology toolkit as an aid to clinical diagnosis.

Roche's anti-TIGIT antibody tiragolumab has failed a second phase 3 trial, dousing expectations for the programme and its hopes of finding a companion to its cancer immunotherapy blockbuster ...

Get Roche Holding AG (ROG.S) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ...